This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Limbruno, U. Articles by Mariani, M. Search for Related Content PubMed PubMed Citation Articles by Limbruno, U. Articles by Mariani, M. Related Collections Coronary imaging: angiography/ultrasound/Doppler/CC Other diagnostic testing Coronary circulation Endothelium/vascular type/nitric oxide

(Circulation. 2000;101:491.)
© 2000 American Heart Association, Inc.

Clinical Investigation and Reports

The Impact of Coronary Artery Disease on the Coronary Vasomotor Response to Nonionic Contrast Media

Ugo Limbruno, MD, PhD; Anna Sonia Petronio, MD; Giovanni Amoroso, MD; Roberto Baglini, MD, PhD; Giovanni Paterni, MD; Antonella Merelli, RT; Rita Mariotti, MD; Raffaele De Caterina, MD, PhD; Mario Mariani, MD

From the Cardiac and Thoracic Department, University of Pisa; and CNR Institute of Clinical Physiology and Scuola Superiore S. Anna (R.D.), Pisa, Italy.

Correspondence to Ugo Limbruno, MD, PhD, Cardiac and Thoracic Department, Cisanello Hospital, Via Paradisa 2, 56124, Pisa, Italy. E-mail ulimbru{at}tin.it

Background—Coronary artery disease (CAD) alters the vasomotor response to a variety of pharmacological agents. We tested the hypothesis that CAD also has an impact on the coronary vasomotor response to radiologic contrast media.

Methods and Results—We performed quantitative coronary angiography in 42 patients without angiographic evidence of CAD and 38 patients with CAD in the left coronary artery. Angiographically smooth coronary segments (n=235) were analyzed for changes on luminal diameters and coronary venous oxygen saturation in response to 3 media: the nonionic dimer iodixanol, the nonionic monomer iopromide, and the ionic agent ioxaglate. In subjects without CAD, we assessed the effects of intracoronary administration of the nitric oxide synthase inhibitor N^G-monomethyl-L-arginine and of the cyclooxygenase inhibitor indomethacin on such changes. Iodixanol induced coronary vasodilation in subjects without CAD (8.8±8.6%, P<0.001). Patients with CAD exhibited no significant diameter changes in segments 20 mm apart from a stenosis (4.7±9.4%, P=NS) and significant constriction in segments <20 mm from a stenosis (-3.8±4.6%, P<0.05). Similar results were obtained with iopromide, but no changes were found with ioxaglate. All contrast media induced transient (<35 seconds) increases in coronary venous oxygen saturation in all subjects. Indomethacin, but not N^G-monomethyl-L-arginine, blunted the vasodilating effect of iodixanol and iopromide (by 80% and 76%, respectively; P<0.001).

Conclusions—Nonionic contrast media induce a vasodilatory response in normal vessels not by a mechanism involving increased flow or endothelial nitric oxide synthesis, but rather by depending on preserved vascular cyclooxygenase activity. CAD changes normal epicardial vasodilatory response into vasoconstriction.

Key Words: contrast media • coronary disease • vasoconstriction • vasodilation • endothelium-derived factors

This article has been cited by other articles:

				U. Limbruno, A. Micheli, M. De Carlo, G. Amoroso, R. Rossini, C. Palagi, V. Di Bello, A. S. Petronio, G. Fontanini, and M. Mariani Mechanical Prevention of Distal Embolization During Primary Angioplasty: Safety, Feasibility, and Impact on Myocardial Reperfusion Circulation, July 15, 2003; 108(2): 171 - 176. [Abstract] [Full Text] [PDF]

				L. Gregorini, J. Marco, B. Farah, M. Bernies, C. Palombo, M. Kozakova, I. M. Bossi, B. Cassagneau, J. Fajadet, C. Di Mario, et al. Effects of Selective {alpha}1- and {alpha}2-Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting Circulation, December 3, 2002; 106(23): 2901 - 2907. [Abstract] [Full Text] [PDF]

				W.B. Batchelor From COURT to HOMBURG: in search of the optimal contrast agent Eur. Heart J., November 1, 2001; 22(21): 2026 - 2028. [PDF]